We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

033780:KRXKT&G Corporation Analysis

Data as of 2026-06-14 - not real-time

₩187,800.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

KT&G delivered a robust Q1 FY2026, with consolidated revenue climbing 14.3% YoY to KRW 1.70 trillion and operating profit jumping 27.6% to KRW 364.5 billion, while net income surged 46.6% to KRW 378.2 billion. The company’s profit margins remain solid (gross 46.97%, operating 21.40%, net 17.89%) and it continues to return cash to shareholders with a 3.19% dividend yield and a 52% payout ratio, supported by strong operating cash flow of KRW 869 billion. Technically, the stock trades at KRW 187,800, comfortably above its 20‑day SMA (182,295) and 50‑day SMA (174,936), yet just shy of the 200‑day SMA (152,685) and sits near the resistance level of KRW 190,000; the RSI of 59.5 signals moderate momentum, while a bearish MACD histogram hints at a short‑term pull‑back. Valuation metrics show a forward P/E of 14.3 and a price‑to‑sales of 2.87, placing the current price below the analyst consensus target of KRW 207,000 (≈11% upside).
Given the low beta of 0.16, stable volume, and a dividend yield that exceeds the sector average, the stock offers defensive characteristics with growth upside. However, the tobacco industry carries high sector and regulatory risk, and the 30‑day volatility of 37.6% underscores price swings. Overall, the fundamentals are strong, the dividend appears sustainable, and the upside potential relative to targets justifies a bullish stance for the medium to long term, while a cautious hold is prudent in the near term.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near resistance at KRW 190,000
  • Bearish MACD histogram suggesting short‑term weakness
  • Strong dividend yield providing downside cushion

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Analyst consensus target price ~KRW 207,000 (~11% upside)
  • Robust earnings growth and expanding profit margins
  • Sustainable dividend with a 52% payout ratio

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Low beta (0.16) indicating defensive stability
  • Diversified product portfolio beyond cigarettes (ginseng, health foods)
  • Strong cash generation supporting dividend continuity

Key Metrics & Analysis

Financial Health

Revenue Growth14.30%
Profit Margin17.89%
P/E Ratio14.3
ROE13.19%
ROA6.18%
Debt/Equity18.78
Op. Cash Flow₩869.4B
Free Cash Flow₩206.9B

Technical Analysis

TrendBullish
RSI59.5
Support₩173,200.00
Resistance₩190,000.00
MA 20₩182,295.00
MA 50₩174,936.00
MA 200₩152,685.00
MACDBearish
VolumeStable
Fear & Greed Index89.86

Valuation

Fair Value₩47,590.69
Target Price₩210,166.67
Upside/Downside11.91%
GradeUndervalued
TypeBlend
Dividend Yield3.19%

Risk Assessment

Beta0.17
Volatility37.60%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.